REAL-TIME GLOBAL RESEARCH
Risk Reward Update
Research evidence excerpt
Risk Reward Update
UpdateM
RiskRisk RewardReward– Dexus-(DXS.AX)Dexus (DXS.AX)
Cheap valuation, but weak FFO growth; UW
PRICE TARGET A$6.40 UNDERWEIGHT THESIS
We derive our PT via a 10/50/40 weighting to our Bull/Base/Bear cases, given our view that DXS collects c.70% of income from Office
asset-heavy Office owners may struggle to excel, even if the Office cycle recovers, because of rent, of which 50-55% is from Sydney
incentives/abatements. Each is derived using DCF (75%) and NAV (25%). CBD/fringe assets. Thus DXS's stock is
driven by the state of the Sydney office
DCF (Base Case A$6.36) is driven by 9.9% CoE (0.9 beta), and a 3% terminal growth rate. market.
NAV (Base Case A$8.64) is premised on a flat cap rate across the Office and Industrial Our concern for the next 12 months is that
portfolios. Office is unlikely to have any material
recovery, with incentives staying high, even
A$6.53 if face rents were to improve, especially as
Consensus Price Target Distribution A$6.07 A$7.03 vacancy remains above the long-term
MS PT average. In the medium term, we are
Source: Refinitiv, Morgan Stanley Research Mean Morgan Stanley Estimates concerned about broader cash flow risks
stemming from refurbishment requirements.
RISK REWARD CHART We are also cautious on a few stock-specific
issues for DXS, such as slowness around
overall funds management growth, and
AUD A$9.10A$9.10(+56.90%)A$9.10(+56.90%)(+56.90%) Atlassian HQ dilution/ recapitalisation.
8 Consensus Rating Distribution
30% Overweight
A$6.40A$6.40(+10.34%)A$6.40(+10.34%)(+10.34%)
6 A$5.80A$5.80A$5.80 60% Equal-weight
10% Underweight
A$5.10A$5.10(-12.07%)A$5.10(-12.07%)(-12.07%) MS Rating
Source: Refinitiv, Morgan Stanley Research
Risk Reward Themes
Disruption: Negative
0 Pricing Power: Negative
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer